Table 2.
Comparison of Placebo (n = 10) vs. 4 g a day Omega 3 (n = 11) for Study Completers at Baseline, Week 4, Week 8, and Week 12 on the motivational symptoms and higher-order cognitive function subscales of the Cognitive Physical Functioning Questionnaire (CPFQ).
| CPFQ: Motivational Symptoms (3 items) |
CPFQ: Higher-Order Cognitive Function (4 items) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Placebo | 4 g/d EPA | p | Cohen's D [95% CI] | Placebo | 4 g/d EPA | p | Cohen's D [95% CI] | ||
| Baseline | Mean (SD) | 11.30 (2.63) | 11.73 (1.95) | .67 | −.20 [-1.05, .67] | 14.10 (3.51) | 11.64 (2.42) | .07 | .87 [-.04, 1.76] |
| Week 4 | Mean (SD) | 10.20 (2.10) | 8.73 (3.85) | .29 | .49 [-.38, 1.36] | 12.20 (2.57) | 9.91 (2.21) | .04 | 1.01 [.08, 1.91] |
| Week 8 | Mean (SD) | 9.30 (3.06) | 7.36 (2.77) | .14 | .70 [-.19, 1.58] | 11.20 (3.29) | 9.27 (2.57) | .15 | .69 [-.20, 1.57] |
| Week 12 | Mean (SD) | 9.10 (2.51) | 7.00 (3.03) | .10 | .79 [-.11, 1.67] | 10.70 (2.91) | 9.18 (1.94) | .17 | .65 [-.24, 1.53] |